Atlas Trials

Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

Clinical trial NCT03495024 · RECRUITING

Trial details

NCT number
NCT03495024
Sponsor
Corporal Michael J. Crescenz VA Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderTobacco SmokingTardive DyskinesiaParkinsonism
Start date
2019-01-01
Primary completion
2020-04-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.